Carcinome hépatocellulaire et transplantation hépatique : état des lieux

作者: J. Lerut

DOI: 10.1016/S0021-7697(07)89481-6

关键词: TransplantationAdjuvant therapySurgeryIncidence (epidemiology)Hepatocellular carcinomaTumor progressionMedicineNodule (medicine)Liver transplantationMilan criteria

摘要: Hepatic transplantation offers the best treatment for cure hepatocellular carcinoma arising in cirrhotic liver as long patients and indications are carefully selected. The Milan criteria which became established 1990's showed that results obtained when there three or fewer nodules less than 3 cm size, a single nodule five cm. size. Today, these seem to be too restrictive, surgery can extended by employing based on macroscopic findings, histology, even molecular biology. It is necessary not only better define limits of therapy but also keep close watch awaiting transplant prevent exclusion from list due tumor progression. Results improved decreasing late recurrence with an optimal postoperative immunosuppressive regimen adjuvant chemotherapy. choice using living donor transplanting marginal quality should weighed against characteristics anticipated waiting period liver. increasing incidence imposes need offer curative more we able do under current circumstances. strategies cancer multidisciplinary start; use all available tools including evaluated multicentric studies.

参考文章(48)
Tito Livraghi, Radiofrequency ablation, PEIT, and TACE for hepatocellular carcinoma. Journal of Hepato-biliary-pancreatic Surgery. ,vol. 10, pp. 67- 76 ,(2003) , 10.1007/S10534-002-0714-Y
Shunzaburo Iwatsuki, Igor Dvorchik, J.Wallis Marsh, Juan R Madariaga, Brian Carr, John J Fung, Thomas E Starzl, Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. Journal of The American College of Surgeons. ,vol. 191, pp. 389- 394 ,(2000) , 10.1016/S1072-7515(00)00688-8
G. Colella, G. F. Rondinara, L. De Carlis, C. V. Sansalone, A. O. Slim, P. Aseni, O. Rossetti, A. De Gasperi, E. Minola, R. Bottelli, L. S. Belli, G. Ideo, D. Forti, Liver transplantation for hepatocellular carcinoma: prognostic factors associated long-term survival Transplant International. ,vol. 9, pp. 109- 111 ,(1996) , 10.1007/978-3-662-00818-8_28
Sven Jonas, Wolf O Bechstein, Thomas Steinmüller, Martin Herrmann, Cornelia Radke, Thomas Berg, Utz Settmacher, Peter Neuhaus, Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis Hepatology. ,vol. 33, pp. 1080- 1086 ,(2001) , 10.1053/JHEP.2001.23561
Pietro E. Majno, René Adam, Henri Bismuth, Denis Castaing, Arie Ariche, Jinane Krissat, Hubert Perrin, Daniel Azoulay, Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Annals of Surgery. ,vol. 226, pp. 688- 703 ,(1997) , 10.1097/00000658-199712000-00006
Yasuhiko Sugawara, Masatoshi Makuuchi, Tadatoshi Takayama, Hiroshi Imamura, Living-related liver transplantation for primary biliary cirrhosis. Transplantation. ,vol. 72, pp. 1087- 1091 ,(2001) , 10.1097/00007890-200109270-00018
P. M. LOPEZ, A. VILLANUEVA, J. M. LLOVET, Systematic review: evidence‐based management of hepatocellular carcinoma – an updated analysis of randomized controlled trials Alimentary Pharmacology & Therapeutics. ,vol. 23, pp. 1535- 1547 ,(2006) , 10.1111/J.1365-2036.2006.02932.X
Satoshi Kaihara, Tetsuya Kiuchi, Mikiko Ueda, Fumitaka Oike, Yasuhiro Fujimoto, Kohei Ogawa, Koichi Kozaki, Koichi Tanaka, Living-donor liver transplantation for hepatocellular carcinoma. Transplantation. ,vol. 75, pp. 37- 40 ,(2003) , 10.1097/01.TP.0000047029.02806.16
Russell H. Wiesner, Richard B. Freeman, David C. Mulligan, Liver transplantation for hepatocellular cancer: The impact of the MELD allocation policy Gastroenterology. ,vol. 127, pp. 261- 267 ,(2004) , 10.1053/J.GASTRO.2004.09.040